These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32601084)

  • 1. Decision to reject screening for familial hypercholesterolaemia is flawed.
    Wald DS; Martin AC
    Arch Dis Child; 2021 Jun; 106(6):525-526. PubMed ID: 32601084
    [No Abstract]   [Full Text] [Related]  

  • 2. Further response to 'Decision to reject screening for familial hypercholesterolaemia is flawed' by Wald and Martin.
    Wald DS; Martin AC
    Arch Dis Child; 2022 Jan; 107(1):102-103. PubMed ID: 34656980
    [No Abstract]   [Full Text] [Related]  

  • 3. How To Identify Familial Premature Myocardial Infarction: Comparing Approaches To Identify Familial Hypercholesterolemia.
    Beheshti S; Madsen CM; Varbo A; Nordestgaard BG
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2657-2667. PubMed ID: 30753598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. People at risk of familial hypercholesterolaemia should have DNA test, says NICE.
    BMJ; 2017 Nov; 359():j5112. PubMed ID: 29097374
    [No Abstract]   [Full Text] [Related]  

  • 5. Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis.
    McKay AJ; Hogan H; Humphries SE; Marks D; Ray KK; Miners A
    Atherosclerosis; 2018 Aug; 275():434-443. PubMed ID: 29937236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses to 'Decision to reject screening for familial hypercholesterolaemia is flawed' by Wald and Martin.
    Marshall J; Shortland Obe G; Hillier S; Brownsword R; Steele B
    Arch Dis Child; 2022 Jan; 107(1):102. PubMed ID: 34289993
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutation screening in patients for familial hypercholesterolaemia (ADH).
    Taylor A; Patel K; Tsedeke J; Humphries SE; Norbury G
    Clin Genet; 2010 Jan; 77(1):97-9. PubMed ID: 19843101
    [No Abstract]   [Full Text] [Related]  

  • 8. The UK National Screening Committee's position on child-parent screening for familial hypercholesterolaemia.
    Wald DS; Neely D
    J Med Screen; 2021 Sep; 28(3):217-220. PubMed ID: 34292841
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
    Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
    Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part.
    Brett T; Qureshi N; Gidding S; Watts GF
    Atherosclerosis; 2018 Oct; 277():399-406. PubMed ID: 30270077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.
    Lee C; Cui Y; Song J; Li S; Zhang F; Wu M; Li L; Hu D; Chen H
    Lipids Health Dis; 2019 Apr; 18(1):95. PubMed ID: 30971288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the diagnosis and management of familial hypercholesterolaemia.
    Sullivan D;
    Heart Lung Circ; 2007 Feb; 16(1):25-7. PubMed ID: 17188936
    [No Abstract]   [Full Text] [Related]  

  • 13. Universal screening of children for familial hypercholesterolaemia: Value for money?
    Ademi Z; Martin AC
    Atherosclerosis; 2018 Aug; 275():384-386. PubMed ID: 29961599
    [No Abstract]   [Full Text] [Related]  

  • 14. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.
    Wald DS; Bestwick JP
    Atherosclerosis; 2020 Jan; 293():57-61. PubMed ID: 31837509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
    Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic unexceptionalism: clinician accounts of genetic testing for familial hypercholesterolaemia.
    Will CM; Armstrong D; Marteau TM
    Soc Sci Med; 2010 Sep; 71(5):910-7. PubMed ID: 20591544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic screening for familial hypercholesterolaemia in Hong Kong.
    Tan K; Cheung CL; Yeung CY; Siu D; Leung J; Pang HK
    Hong Kong Med J; 2018 Jun; 24 Suppl 3(3):7-10. PubMed ID: 29937437
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study.
    Talmud PJ; Shah S; Whittall R; Futema M; Howard P; Cooper JA; Harrison SC; Li K; Drenos F; Karpe F; Neil HA; Descamps OS; Langenberg C; Lench N; Kivimaki M; Whittaker J; Hingorani AD; Kumari M; Humphries SE
    Lancet; 2013 Apr; 381(9874):1293-301. PubMed ID: 23433573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial hypercholesterolemia: recognition and prevention of cardiac complications at a young age].
    Trip MD; Lansberg PJ; de Jongh S; Kastelein JJ
    Ned Tijdschr Geneeskd; 2000 Jul; 144(30):1425-8. PubMed ID: 10932693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnic access to child-parent screening for familial hypercholesterolaemia.
    Wald DS; Bestwick JP
    Eur J Prev Cardiol; 2019 Aug; 26(12):1341-1342. PubMed ID: 30971125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.